Harvard Bioscience Inc. (NASDAQ: HBIO)
$3.53
+0.2100 ( +6.33% ) 145.5K
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
Market Data
Open
$3.53
Previous close
$3.32
Volume
145.5K
Market cap
$153.74M
Day range
$3.33 - $3.55
52 week range
$2.70 - $5.56
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 5 | Apr 03, 2024 |
8-k | 8K-related | 14 | Apr 03, 2024 |
8-k | 8K-related | 13 | Mar 26, 2024 |
4 | Insider transactions | 1 | Mar 07, 2024 |
10-k | Annual reports | 117 | Mar 07, 2024 |
8-k | 8K-related | 16 | Mar 07, 2024 |
4 | Insider transactions | 1 | Mar 07, 2024 |
8-k | 8K-related | 31 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |